标题
Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 40, Pages 11469
出版商
Baishideng Publishing Group Inc.
发表日期
2015-10-28
DOI
10.3748/wjg.v21.i40.11469
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Disease Activity Assessment in IBD
- (2015) James D. Falvey et al. INFLAMMATORY BOWEL DISEASES
- Prediction of Endoscopic Disease Activity in Ulcerative Colitis by Two Different Assays for Fecal Calprotectin
- (2014) V. Kristensen et al. Journal of Crohns & Colitis
- Moving towards disease modification in inflammatory bowel disease therapy
- (2013) Patrick B. Allen et al. CURRENT OPINION IN GASTROENTEROLOGY
- A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis
- (2013) Triana Lobatón et al. INFLAMMATORY BOWEL DISEASES
- Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases
- (2013) Stephane Nancey et al. INFLAMMATORY BOWEL DISEASES
- A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease
- (2013) Triana Lobatón et al. Journal of Crohns & Colitis
- Evaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test
- (2012) Asuka Nakarai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treatment of Fibrostenotic and Fistulizing Crohns Disease
- (2012) Alain M. Schoepfer et al. DIGESTION
- Mucosal healing in inflammatory bowel diseases: a systematic review
- (2012) Markus F Neurath et al. GUT
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
- (2012) Geert DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- Changing Crohn's disease management: Need for new goals and indices to prevent disability and improve quality of life
- (2012) Daniel Hommes et al. Journal of Crohns & Colitis
- Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD
- (2012) Pauliina Molander et al. Journal of Crohns & Colitis
- Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
- (2012) Marzena Komraus et al. MEDIATORS OF INFLAMMATION
- Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
- (2012) Clas-Göran af Björkesten et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease
- (2011) Tomoki Aomatsu et al. DIGESTIVE DISEASES AND SCIENCES
- Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome
- (2011) Michael J. Sydora et al. Journal of Crohns & Colitis
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response
- (2010) D. Turner et al. GUT
- Utility of Fecal Lactoferrin in Identifying Crohn Disease Activity in Children
- (2010) Marian D Pfefferkorn et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI
- (2009) Alain M Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ulcerative colitis
- (2009) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Clinical implications of mucosal healing for the management of IBD
- (2009) Guillaume Pineton de Chambrun et al. Nature Reviews Gastroenterology & Hepatology
- Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
- (2009) Taina Sipponen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings
- (2008) T. SIPPONEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
- (2008) Jennifer Jones et al. Clinical Gastroenterology and Hepatology
- Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
- (2008) R. Berni Canani et al. DIGESTIVE AND LIVER DISEASE
- Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease
- (2008) Taina Sipponen et al. INFLAMMATORY BOWEL DISEASES
- Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices
- (2007) Jost Langhorst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
- (2007) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings
- (2007) Taina Sipponen et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started